Breakthrough therapies—
discovered faster than ever

Powered by an AI-native discovery engine and a relentless team, we turn complex chemistry into viable drug candidates across some of the toughest diseases—with speed and rigor.

We have built momentum from first experiments to a growing pipeline—and we’re only accelerating.

Many Inspithera molecules have
already advanced into R&D.
Watch their progress.

12 Development Candidates

01 Clinical Programs

CSM004

Mechanism: —

Indication: CNS

Granted

CSM045

Mechanism: —

Indication: Anti-Diabetes

Complete Filed

CSM050

Mechanism: —

Indication: Anti-Parkinson's

Complete Filed

CSM027

Mechanism: —

Indication: Hypertension

Provisional Filed

CSM046

Mechanism: —

Indication: Pain Management

Provisional Filed

CSM047

Mechanism: —

Indication: Pain Management

Provisional Filed

CSM048

Mechanism: —

Indication: Pain Management

Provisional Filed

CSM049

Mechanism: —

Indication: Appetite suppressant

Provisional Filed

CSM051

Mechanism: —

Indication: Anticonvulsant

Provisional Filed

CSM052

Mechanism: —

Indication: Pain Management

Provisional Filed

CSM053

Mechanism: —

Indication: CNS

Provisional Filed

CSM054

Mechanism: —

Indication: Antineoplastic

Provisional Filed

CSM055

Mechanism: —

Indication: Antiarrhythmic

Provisional Filed

CSM056

Mechanism: —

Indication: AntiCytomegalovirus

Provisional Filed

CSM057

Mechanism: —

Indication: Anticonvulsants

Provisional Filed

CSM058

Mechanism: —

Indication: Antineoplastic

Provisional Filed

CSM059

Mechanism: —

Indication: Antineoplastic

Provisional Filed

CSM060

Mechanism: —

Indication: Pain Management

Provisional Filed

CSM061

Mechanism: —

Indication: Hypertension

Provisional Filed

CSM062

Mechanism: —

Indication: Progesterone Antagonist

Provisional Filed

CSM063

Mechanism: —

Indication: CNS

Provisional Filed

Name

Mechanism

Indication

Discovery

Optimization

IND-Enabling

Phase 1

Phase 1b/2a

CSM004

—

CNS

CSM004 — Therapeutic Area: CNS. IP Status: Granted.

CSM045

—

Anti-Diabetes

CSM045 — Therapeutic Area: Anti-Diabetes. IP Status: Complete Filed.

CSM050

—

Anti-Parkinson's

CSM050 — Therapeutic Area: Anti-Parkinson’s. IP Status: Complete Filed.

CSM027

—

Hypertension

CSM027 — Therapeutic Area: Hypertension. IP Status: Provisional Filed.

CSM046

—

Pain Management

CSM046 — Therapeutic Area: Pain Management. IP Status: Provisional Filed.

CSM047

—

Pain Management

CSM047 — Therapeutic Area: Pain Management. IP Status: Provisional Filed.

CSM048

—

Pain Management

CSM048 — Therapeutic Area: Pain Management. IP Status: Provisional Filed.

CSM049

—

Appetite suppressant

CSM049 — Therapeutic Area: Appetite suppressant. IP Status: Provisional Filed.

CSM051

—

Anticonvulsant

CSM051 — Therapeutic Area: Anticonvulsant. IP Status: Provisional Filed.

CSM052

—

Pain Management

CSM052 — Therapeutic Area: Pain Management. IP Status: Provisional Filed.

CSM053

—

CNS

CSM053 — Therapeutic Area: CNS. IP Status: Provisional Filed.

CSM054

—

Antineoplastic

CSM054 — Therapeutic Area: Antineoplastic. IP Status: Provisional Filed.

CSM055

—

Antiarrhythmic

CSM055 — Therapeutic Area: Antiarrhythmic. IP Status: Provisional Filed.

CSM056

—

AntiCytomegalovirus

CSM056 — Therapeutic Area: AntiCytomegalovirus. IP Status: Provisional Filed.

CSM057

—

Anticonvulsants

CSM057 — Therapeutic Area: Anticonvulsants. IP Status: Provisional Filed.

CSM058

—

Antineoplastic

CSM058 — Therapeutic Area: Antineoplastic. IP Status: Provisional Filed.

CSM059

—

Antineoplastic

CSM059 — Therapeutic Area: Antineoplastic. IP Status: Provisional Filed.

CSM060

—

Pain Management

CSM060 — Therapeutic Area: Pain Management. IP Status: Provisional Filed.

CSM061

—

Hypertension

CSM061 — Therapeutic Area: Hypertension. IP Status: Provisional Filed.

CSM062

—

Progesterone Antagonist

CSM062 — Therapeutic Area: Progesterone Antagonist. IP Status: Provisional Filed.

CSM063

—

CNS

CSM063 — Therapeutic Area: CNS. IP Status: Provisional Filed.

Development Candidate Declared

Help shape what comes next

Our focus today: therapeutics.
On the horizon: resilient agriculture, smarter nutrition, sustainable materials, and more.

By working together, we can rapidly expand the map of nature’s chemistry
and tackle pressing challenges across human and planetary health.
If this mission resonates, we’d love to connect.

Breakthrough therapies— discovered faster than ever

Many Inspithera molecules have already advanced into R&D. Watch their progress.

CSM004

CSM045

CSM050

CSM027

CSM046

CSM047

CSM048

CSM049

CSM051

CSM052

CSM053

CSM054

CSM055

CSM056

CSM057

CSM058

CSM059

CSM060

CSM061

CSM062

CSM063

Help shape what comes next

Our focus today: therapeutics. On the horizon: resilient agriculture, smarter nutrition, sustainable materials, and more.

Breakthrough therapies—
discovered faster than ever

Many Inspithera molecules have
already advanced into R&D.
Watch their progress.

Our focus today: therapeutics.
On the horizon: resilient agriculture, smarter nutrition, sustainable materials, and more.